Overall rank by patents
#30,823
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 16 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B23B (TURNING; Boring).
The verdict
According to USPTO PatentsView, Amvalor ranks #30,823 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 16 technology areas.
USPTO PatentsView assignee plate
Corpus R30823 · Foreign Corporation #30,823 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Amira Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Amvalor · this assignee
35 score
3D Lighting… · lowest
7 score
What this shows Amvalor's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Amvalor is a focused PatentsView assignee: 16 CPC subclasses with 50% of grants classified under B23B (TURNING; Boring). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2018. By volume, Amvalor sits between Amira Pharmaceuticals, Inc. and Angle North America, Inc..
Amvalor shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Amira Pharmaceuticals, Inc.
8 patents
Amita Technologies Inc.
8 patents
Ampac Limited
8 patents
Ampsource Biopharma Shanghai Inc.
8 patents
Anaergia B.V.
8 patents
Analogix International LLC
8 patents
Angelcare Feeding USA, LLC
8 patents
Angle North America, Inc.
8 patents
Amvalor
8 patents
What this shows Amvalor holds 8 patents at rank #30,772, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,772 in granted patent volume.
Other assignees with the most granted patents in Amvalor's primary technology class.
Amvalor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2022 | 3 | 37.5% |
| 2025partial year | 1 | 12.5% |
Top 15 of 16 technology areas
Overall rank by patents
#30,823
of 49,997 tracked assignees
35.2 out of 100
What to do with this data
Amvalor's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.